Mitochondrial DNA nucleotide changes in non-arteritic ischemic optic neuropathy

Area of Science:

• Ophthalmology
• Genetics
• Mitochondrial Biology

Background:

• Non-arteritic anterior ischemic optic neuropathy (NAION) is a leading cause of sudden blindness in adults.
• The underlying causes and risk factors for NAION remain incompletely understood.
• Mitochondrial dysfunction has been implicated in various neurodegenerative diseases.

Purpose of the Study:

• To investigate the role of mitochondrial DNA (mtDNA) mutations in the pathogenesis of NAION.
• To compare mtDNA coding regions between NAION patients and healthy controls.

Main Methods:

• Whole mitochondrial DNA coding region sequencing was performed.
• Genetic variations, including synonymous and nonsynonymous nucleotide changes, were analyzed.
• The potential pathogenicity of identified mutations was assessed based on amino acid conservation and functional domains.

Main Results:

• NAION patients exhibited a significantly higher frequency of nucleotide changes in their mtDNA coding regions compared to controls (p < 0.001).
• Twelve potentially pathogenic variations were identified in NAION patients, with eleven being novel.
• Nine of these variations altered moderately or highly conserved amino acids within critical functional domains of mitochondrial proteins.

Conclusions:

• Mitochondrial DNA variations are more common in individuals with NAION.
• These genetic alterations may contribute to mitochondrial malfunction, suggesting a potential risk factor for NAION development.
• Further research into mitochondrial genetics could offer new insights into NAION pathogenesis and potential therapeutic targets.